Michael Billard

Michael Billard is the Vice President of Project Execution at Adaptive Phage Therapeutics. With a background in chemistry and biotechnology, Michael has held various executive and managerial positions in companies like Propella Therapeutics, Paragon Bioservices, Martek Biosciences, and DSM. Prior to their career in the biotech industry, Michael served as a Chemical Officer in the U.S. Army. Michael holds a Master of Science in Biotechnology from The Johns Hopkins University and a Bachelor of Science in Chemistry from Illinois State University.